Bank of New York Mellon
ASXC

Bank of New York Mellon’s Asensus Surgical, Inc. ASXC Stock Holding History

Bank of New York Mellon’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,195
Closed -$8.06K – 4190
2024
Q2 		$8.06K Hold
24,195
– – ﹤0.01% 4105
2024
Q1 		$5.57K Sell
24,195
-99,974
-81% -$29K ﹤0.01% 4136
2023
Q4 		$39.6K Hold
124,169
– – ﹤0.01% 4178
2023
Q3 		$33.5K Hold
124,169
– – ﹤0.01% 4204
2023
Q2 		$62.7K Hold
124,169
– – ﹤0.01% 4141
2023
Q1 		$81.7K Hold
124,169
– – ﹤0.01% 4104
2022
Q4 		$43.1K Hold
124,169
– – ﹤0.01% 4260
2022
Q3 		$56K Hold
124,169
– – ﹤0.01% 4303
2022
Q2 		$49K Sell
124,169
-679,972
-85% -$303K ﹤0.01% 4350
2022
Q1 		$504K Sell
804,141
-13,552
-2% -$10.4K ﹤0.01% 3707
2021
Q4 		$907K Sell
817,693
-13,437
-2% -$20.8K ﹤0.01% 3438
2021
Q3 		$1.54M Buy
831,130
+133,206
+19% +$299K ﹤0.01% 3156
2021
Q2 		$2.21M Buy
697,924
+628,157
+900% +$1.57M ﹤0.01% 2921
2021
Q1 		$227K Buy
69,767
+59,381
+572% +$215K ﹤0.01% 4012
2020
Q4 		$6K Hold
10,386
– – ﹤0.01% 4208
2020
Q3 		$4K Hold
10,386
– – ﹤0.01% 4110
2020
Q2 		$6K Sell
10,386
-54,740
-84% -$26.4K ﹤0.01% 4074
2020
Q1 		$23K Sell
65,126
-73
-0.1% -$76 ﹤0.01% 4047
2019
Q4 		$96K Buy
65,199
+6,021
+10% +$20.9K ﹤0.01% 4031
2019
Q3 		$477K Sell
59,178
-1,684
-3% -$22.9K ﹤0.01% 3559
2019
Q2 		$1.08M Buy
60,862
+5,101
+9% +$112K ﹤0.01% 3162
2019
Q1 		$1.73M Sell
55,761
-1,306
-2% -$43.8K ﹤0.01% 2848
2018
Q4 		$1.68M Buy
57,067
+15,292
+37% +$695K ﹤0.01% 2822
2018
Q3 		$3.15M Buy
41,775
+3,111
+8% +$211K ﹤0.01% 2615
2018
Q2 		$2.19M Buy
38,664
+27,181
+237% +$990K ﹤0.01% 2801
2018
Q1 		$254K Buy
11,483
+2,284
+25% +$52.3K ﹤0.01% 3847
2017
Q4 		$231K Buy
9,199
+4,457
+94% +$137K ﹤0.01% 3889
2017
Q3 		$88K Sell
4,742
-248
-5% -$2.89K ﹤0.01% 4023
2017
Q2 		$46K Sell
4,990
-24,280
-83% -$231K ﹤0.01% 4143
2017
Q1 		$461K Buy
29,270
+2,934
+11% +$50.9K ﹤0.01% 3588
2016
Q4 		$445K Buy
26,336
+4,087
+18% +$83.8K ﹤0.01% 3644
2016
Q3 		$489K Buy
22,249
+1,627
+8% +$29.7K ﹤0.01% 3550
2016
Q2 		$327K Buy
20,622
+5,228
+34% +$164K ﹤0.01% 3712
2016
Q1 		$851K Buy
15,394
+3,264
+27% +$140K ﹤0.01% 3163
2015
Q4 		$391K Sell
12,130
-5,178
-30% -$167K ﹤0.01% 3625
2015
Q3 		$509K Buy
17,308
+8,320
+93% +$309K ﹤0.01% 3580
2015
Q2 		$350K Buy
8,988
+3
+0% +$138 ﹤0.01% 3739
2015
Q1 		$342K Sell
8,985
-60
-0.7% -$2.26K ﹤0.01% 3741
2014
Q4 		$342K Sell
9,045
-279
-3% -$11.5K ﹤0.01% 3740
2014
Q3 		$528K Buy
9,324
+736
+9% +$39.7K ﹤0.01% 3599
2014
Q2 		$562K Buy
+8,588
New +$496K ﹤0.01% 3568

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of New York Mellon's ASXC Position: Q3 2024 in Review

Bank of New York Mellon sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 24,195 shares — an estimated $8.06K sold.

Bank of New York Mellon first reported a position in ASXC in Q2 2014 and held it in 41 quarters. The position peaked at $3.15M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Bank of New York Mellon reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 24,195 Asensus Surgical, Inc. shares in Q3 2024, an estimated $8.06K.
  • Bank of New York Mellon first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 41 quarters.
  • Bank of New York Mellon's Asensus Surgical, Inc. position peaked at $3.15M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Bank of New York Mellon's 13F filing for Q3 2024, filed 12 Nov 2024.